Efficacy and Feasibility Trial of a Portable Near Infra-Red Hematoma Imager (NIRD-HI)

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-89
SponsorThe Geneva Foundation

About this trial

Traumatic Brain Injury (TBI) is a leading cause of death and disability among military personnel, Veterans, and civilians. One of the most dangerous complications of moderate-to-severe TBI is intracranial hemorrhage (ICH). If not identified and treated promptly, ICH can rapidly lead to worsening neurological damage or death. Current diagnostic tools, such as CT scans, are highly effective but impractical for battlefield or resource-limited environments due to their large size and infrastructure dependency.

The Near-Infrared Detection-Head Imaging (NIRD-HI) system is an innovative, noninvasive device using Near-Infrared Spectroscopy (NIRS) to identify abnormal blood accumulation. Unlike traditional tools, NIRD-HI is compact, lightweight, and portable, making it suitable for remote or austere settings. By dynamically imaging the brain, it generates 3D visualizations that pinpoint the size and location of bleeds, including complex bilateral injuries. This offers a significant improvement over current point-of-injury technologies that lack the resolution to reliably diagnose all forms of ICH.

This study supports the FY24 Combat Readiness Medical Research Program by advancing battlefield diagnostic and triage capabilities. The research will:

* Evaluate NIRD-HI's accuracy compared to CT imaging. * Assess feasibility in real-world acute care settings. * Investigate its ability to monitor changes in ICH over time.

These objectives address the military's need for tools that improve rapid diagnosis and decision-making during emergencies. Implementing this research can revolutionize TBI management. For Service Members, NIRD-HI promises a field-ready solution for early detection, enabling faster intervention and more effective triage. By reducing diagnostic delays, it could save lives and prevent long-term complications. Furthermore, the system supports prolonged field care by providing continuous monitoring of evolving injuries.

The benefits extend to civilian healthcare, particularly in rural or underserved areas lacking advanced imaging. This accessibility can improve trauma care outcomes for millions, reduce the burden on healthcare systems, and provide equitable distribution of life-saving technology. By addressing gaps in battlefield medicine, this project aims to enhance medical readiness and improve survivability in the most challenging environments.

Eligibility criteria

Qualifiers

18 to 89 years of age

Able to provide written informed consent either by self or legally authorized representative

Received head CT imaging on admission

Able to complete at least one NIRD-HI scan within 4 hours of head CT

Disqualifiers

Presence of penetrating or non-survivable injuries

Hemorrhagic shock or large volume transfusion [>3 units of any blood product within

Large open skull wounds, scalp lacerations or surface hematomas prohibiting safe or comfortable sensor placement

Presence of heat tattoos or intracranial metal fixtures

Trial design

Treatments tested in this trial

  • NIRD-HI scan at the time of enrollment
  • Secondary NIRD-HI scan when a planned repeat CT is performed

Treatment groups

80 Participants
are divided into 2 treatment groups

Sponsors and collaborators

The Geneva Foundation

Lead sponsor

Congressionally Directed Medical Research Programs

Collaborator

Uniformed Services University of the Health Sciences

Collaborator